Akutbehandlung des ischämischen Schlaganfalls

Der Radiologe (Impact Factor: 0.43). 04/2012; 52(4). DOI: 10.1007/s00117-012-2314-3


Der ischämische Schlaganfall ist ein medizinischer Notfall, bei dessen Management die schnelle und effektive Zusammenarbeit zwischen Neurologen und Radiologen unabdingbar ist. Die Therapie des akuten ischämischen Schlaganfalls ist zurzeit Gegenstand neuer vielversprechender Entwicklungen wie der strukturellen Optimierung diagnostischer Arbeitsabläufe zur Verkürzung der Zeit bis zur Therapieentscheidung und neuer endovaskulärer Techniken zur Rekanalisierung verschlossener Gefäße. Auch ist in großen klinischen Studien die Effektivität der Thrombolyse in einem erweiterten Zeitfenster von bis zu 4,5 h nachgewiesen und die Bedeutung des Zeitfaktors für das klinische Outcome untermauert worden.

26 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Malignant infarction of the middle cerebral artery (MCA) is associated with an 80% mortality rate. Non-randomised studies have suggested that decompressive surgery reduces this mortality without increasing the number of severely disabled survivors. To obtain sufficient data as soon as possible to reliably estimate the effects of decompressive surgery, results from three European randomised controlled trials (DECIMAL, DESTINY, HAMLET) were pooled. The trials were ongoing when the pooled analysis was planned.
    The Lancet Neurology 03/2007; 6(3):215-22. DOI:10.1016/S1474-4422(07)70036-4 · 21.90 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To find what the mortality rate of space-occupying ('malignant') middle cerebral artery (MCA) infarction is under maximum conservative intensive care. To establish whether any early indicators of survival exist. Prospective descriptive study. Neuro-critical care unit of a university hospital. Fifty-three patients (mean age 64 +/- 10 years) with 'malignant' MCA infarction. Maximum conservative intensive care using a standardized protocol (heparin, osmotherapy, tromethamol, mild hyperventilation). The start of therapy was within 12 h after the onset of symptoms. The Glasgow Coma Scale (GCS) and Scandinavian Stroke Scale (SSS) were recorded daily. A computed tomography (CT) scan was performed on admission, on day 3 and on day 7. SSS, Barthel Index and Rankin Scale of the surviving patients were recorded after 3 months. On admission, the mean GCS was 13 +/- 3 points and mean SSS 18 +/- 7 points. All patients had to undergo mechanical ventilation (23 +/- 26 h after the onset of symptoms) and were comatose after 28 +/- 30 h. Of 53 patients, 37 (70%) suffered brain death in the intensive care unit (ICU) after an average of 90 +/- 59 h. After 3 months 42/53 (79 %) patients had died. The Barthel Index of the surviving patients was 54 +/- 12 points, the SSS 25 +/- 9 points and the Rankin Scale 3 +/- 1 points. The deceased patients had a significantly higher body temperature on admission than the surviving patients (36.8 degrees C vs 36.3 degrees C). The mortality of patients with 'malignant' MCA infarction is very high despite maximum conservative intensive care.
    Intensive Care Medicine 07/1998; 24(6):620-3. DOI:10.1007/s001340050625 · 7.21 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Many patients with stroke are precluded from thrombolysis treatment because the time from onset of their symptoms is unknown. We aimed to test whether a mismatch in visibility of an acute ischaemic lesion between diffusion-weighted MRI (DWI) and fluid-attenuated inversion recovery (FLAIR) MRI (DWI-FLAIR mismatch) can be used to detect patients within the recommended time window for thrombolysis. In this multicentre observational study, we analysed clinical and MRI data from patients presenting between Jan 1, 2001, and May 31, 2009, with acute stroke for whom DWI and FLAIR were done within 12 h of observed symptom onset. Two neurologists masked to clinical data judged the visibility of acute ischaemic lesions on DWI and FLAIR imaging, and DWI-FLAIR mismatch was diagnosed by consensus. We calculated predictive values of DWI-FLAIR mismatch for the identification of patients with symptom onset within 4·5 h and within 6 h and did multivariate regression analysis to identify potential confounding covariates. This study is registered with, number NCT01021319. The final analysis included 543 patients. Mean age was 66·0 years (95% CI 64·7-67·3) and median National Institutes of Health Stroke Scale score was 8 (IQR 4-15). Acute ischaemic lesions were identified on DWI in 516 patients (95%) and on FLAIR in 271 patients (50%). Interobserver agreement for acute ischaemic lesion visibility on FLAIR imaging was moderate (κ=0·569, 95% CI 0·504-0·634). DWI-FLAIR mismatch identified patients within 4·5 h of symptom onset with 62% (95% CI 57-67) sensitivity, 78% (72-84) specificity, 83% (79-88) positive predictive value, and 54% (48-60) negative predictive value. Multivariate regression analysis identified a longer time to MRI (p<0·0001), a lower age (p=0·0009), and a larger DWI lesion volume (p=0·0226) as independent predictors of lesion visibility on FLAIR imaging. Patients with an acute ischaemic lesion detected with DWI but not with FLAIR imaging are likely to be within a time window for which thrombolysis is safe and effective. These findings lend support to the use of DWI-FLAIR mismatch for selection of patients in a future randomised trial of thrombolysis in patients with unknown time of symptom onset. Else Kröner-Fresenius-Stiftung, National Institutes of Health.
    The Lancet Neurology 11/2011; 10(11):978-86. DOI:10.1016/S1474-4422(11)70192-2 · 21.90 Impact Factor
Show more


26 Reads
Available from